Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INSULET CORPPODD · Entity 3516 | EVP, CFO | July 03, 2023 | July 06, 2023 |
| Solventum CorpSOLV · Entity 1645 | Chief Financial Officer | May 13, 2026 | May 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INSULET CORP
Report date July 03, 2023 · Filed July 06, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,477 |
Reported balance
After 2023-07-03 transaction · row 1
1 source rowRow 1 · 2023-07-03 · Sale · Disposed 1,388 · Balance 21,477 F1: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $281.15 to $286.61. Specifically: 503 shares were sold in the range of $281.15 to $281.79, with a weighted average share price of $281.53; 210 shares were sold in the range of $282.37 to $283.37, with a weighted average share price of $283.01; F2: Footnote continued: 588 shares were sold in the range of $283.44 to $284.39 with a weighted average share price of $283.81; 70 shares were sold at a price of $284.70; and 17 shares were sold at a price of $286.61. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $281.15 to $286.61. Specifically: 503 shares were sold in the range of $281.15 to $281.79, with a weighted average share price of $281.53; 210 shares were sold in the range of $282.37 to $283.37, with a weighted average share price of $283.01;
F2: Footnote continued: 588 shares were sold in the range of $283.44 to $284.39 with a weighted average share price of $283.81; 70 shares were sold at a price of $284.70; and 17 shares were sold at a price of $286.61. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
Solventum Corp
Report date May 13, 2026 · Filed May 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 48,637 |
Ending reported balance
After 2026-05-13 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-13 · Exercise / conversion · Acquired 9,503 · Balance 53,041 Row 2 · 2026-05-13 · Tax withholding · Disposed 4,404 · Balance 48,637 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2034-05-13 | Direct | 9,504 |
Reported balance
After 2026-05-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-13 · Exercise / conversion · Disposed 9,503 · Balance 9,504 F1: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. F2: The RSUs shall fully vest in three tranches, with one-third vesting on each of May 13, 2025; May 13, 2026; and May 13, 2027, subject to continued service through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
F2: The RSUs shall fully vest in three tranches, with one-third vesting on each of May 13, 2025; May 13, 2026; and May 13, 2027, subject to continued service through the vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HOLOGIC INC
Report date April 07, 2026 · Filed April 09, 2026
Section 16 reporting ended · disclosed 2026-04-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 1
1 source rowRow 1 · 2026-04-07 · Disposition to issuer · Disposed 4,932 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the "Merger Agreement"), by and among Hologic, Inc. ("Hologic" or "Company"), Hopper Parent Inc., a Delaware corporation ("Parent"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Hologic common stock, par value $0.01 ("Company Common Stock"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the "Cash Consideration") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a "CVR") (the consideration contemplated by clauses (x) and (y), together, the "Merger Consideration"). F2: At the Effective Time, each time-vesting restricted stock unit award (a "Company RSU Award") held directly by the reporting person was converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock underlying the Company RSU Award. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $61.27 · Expires 2035-04-07 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-04-07 · Disposition to issuer · Disposed 5,171 · Balance 0 F3: For Footnote (3), see Remarks below. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the "Merger Agreement"), by and among Hologic, Inc. ("Hologic" or "Company"), Hopper Parent Inc., a Delaware corporation ("Parent"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Hologic common stock, par value $0.01 ("Company Common Stock"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the "Cash Consideration") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a "CVR") (the consideration contemplated by clauses (x) and (y), together, the "Merger Consideration").
F2: At the Effective Time, each time-vesting restricted stock unit award (a "Company RSU Award") held directly by the reporting person was converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock underlying the Company RSU Award. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock.
F3: For Footnote (3), see Remarks below.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 13, 2026 Filed May 15, 2026 20:11 UTC | Solventum Corp SOLV · Entity 1645 | Exercise / conversionRestricted Stock Units · Derivative | 9,503 | $0.00 | $0.00 |
DisclosureSEC source: 0001768648-26-000005 · wk-form4_1778875863.xml · derivative · entry 3 McMillan Wayde D. · CIK 0001768648 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,504 Underlying: Common Stock · 9,503 shares Expires 2034-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. F2 · derivative.exercise_date: The RSUs shall fully vest in three tranches, with one-third vesting on each of May 13, 2025; May 13, 2026; and May 13, 2027, subject to continued service through the vesting date. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:11 UTC | Solventum Corp SOLV · Entity 1645 | Tax withholdingCommon Stock | 4,404 | $74.41 | $327,701.64 |
DisclosureSEC source: 0001768648-26-000005 · wk-form4_1778875863.xml · nonDerivative · entry 2 McMillan Wayde D. · CIK 0001768648 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,637 Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:11 UTC | Solventum Corp SOLV · Entity 1645 | Exercise / conversionCommon Stock | 9,503 | $0.00 | $0.00 |
DisclosureSEC source: 0001768648-26-000005 · wk-form4_1778875863.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:13 UTC | HOLOGIC INC HOLX · Entity 12463 | Disposition to issuerNon-qualified Stock Option (Right to Buy) · Derivative | 5,171 | Not disclosed Strike: $61.27 | Not disclosed |
DisclosureSEC source: 0000859737-26-000069 · form4.xml · derivative · entry 2 McMillan Wayde D. · CIK 0001768648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,171 shares Expires 2035-04-07 F3 · price: For Footnote (3), see Remarks below. F3 · derivative.exercise_date: For Footnote (3), see Remarks below. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:13 UTC | HOLOGIC INC HOLX · Entity 12463 | Disposition to issuerCommon Stock | 4,932 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000859737-26-000069 · form4.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the "Merger Agreement"), by and among Hologic, Inc. ("Hologic" or "Company"), Hopper Parent Inc., a Delaware corporation ("Parent"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Hologic common stock, par value $0.01 ("Company Common Stock"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the "Cash Consideration") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a "CVR") (the consideration contemplated by clauses (x) and (y), together, the "Merger Consideration"). F2 · price: At the Effective Time, each time-vesting restricted stock unit award (a "Company RSU Award") held directly by the reporting person was converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock underlying the Company RSU Award. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock. Read SEC document |
| March 06, 2026 Filed Mar 9, 2026 23:49 UTC | Solventum Corp SOLV · Entity 1645 | Exercise / conversionRestricted Stock Units · Derivative | 8,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001768648-26-000002 · wk-form4_1773100149.xml · derivative · entry 4 McMillan Wayde D. · CIK 0001768648 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,605 Underlying: Common Stock · 8,802 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement. F2 · derivative.exercise_date: The RSUs shall fully vest in three tranches, with one-third vesting on each of the first, second and third anniversaries of the grant date, subject to continued service through the vesting date. F2 · derivative.expiration_date: The RSUs shall fully vest in three tranches, with one-third vesting on each of the first, second and third anniversaries of the grant date, subject to continued service through the vesting date. Read SEC document |
| March 06, 2026 Filed Mar 9, 2026 23:49 UTC | Solventum Corp SOLV · Entity 1645 | Tax withholdingCommon Stock | 2,786 | $69.41 | $193,376.26 |
DisclosureSEC source: 0001768648-26-000002 · wk-form4_1773100149.xml · nonDerivative · entry 2 McMillan Wayde D. · CIK 0001768648 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,538 Read SEC document |
| March 06, 2026 Filed Mar 9, 2026 23:49 UTC | Solventum Corp SOLV · Entity 1645 | Exercise / conversionCommon Stock | 8,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001768648-26-000002 · wk-form4_1773100149.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 23:49 UTC | Solventum Corp SOLV · Entity 1645 | GrantRestricted Stock Units · Derivative | 35,321 | $0.00 | $0.00 |
DisclosureSEC source: 0001768648-26-000002 · wk-form4_1773100149.xml · derivative · entry 3 McMillan Wayde D. · CIK 0001768648 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,321 Underlying: Common Stock · 35,321 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement. F2 · derivative.exercise_date: The RSUs shall fully vest in three tranches, with one-third vesting on each of the first, second and third anniversaries of the grant date, subject to continued service through the vesting date. F2 · derivative.expiration_date: The RSUs shall fully vest in three tranches, with one-third vesting on each of the first, second and third anniversaries of the grant date, subject to continued service through the vesting date. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 21:22 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 3,190 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000859737-26-000023 · form4.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,932 F1 · shares: Represents restricted stock units which vest on the date of the 2027 Annual Meeting of Stockholders and are settled in shares of common stock. F2 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 22:30 UTC | Solventum Corp SOLV · Entity 1645 | Exercise / conversionRestricted Stock Units · Derivative | 28,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001768648-25-000004 · wk-form4_1764714641.xml · derivative · entry 3 McMillan Wayde D. · CIK 0001768648 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,010 shares Expires 2025-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. F2 · derivative.exercise_date: The RSUs are fully vested. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 22:30 UTC | Solventum Corp SOLV · Entity 1645 | Tax withholdingCommon Stock | 12,980 | $85.56 | $1,110,568.80 |
DisclosureSEC source: 0001768648-25-000004 · wk-form4_1764714641.xml · nonDerivative · entry 2 McMillan Wayde D. · CIK 0001768648 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,522 Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 22:30 UTC | Solventum Corp SOLV · Entity 1645 | Exercise / conversionCommon Stock | 28,010 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001768648-25-000004 · wk-form4_1764714641.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. Read SEC document |
| May 13, 2025 Filed May 15, 2025 20:20 UTC | Solventum Corp SOLV · Entity 1645 | Exercise / conversionRestricted Stock Units · Derivative | 9,502 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-025944 · wk-form4_1747340424.xml · derivative · entry 3 McMillan Wayde D. · CIK 0001768648 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,007 Underlying: Common Stock · 9,502 shares Expires 2034-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement. F2 · derivative.exercise_date: The RSUs shall fully vest in three tranches, with one-third vesting on each of May 13, 2025; May 13, 2026; and May 13, 2027, subject to continued service through the vesting date. Read SEC document |
| May 13, 2025 Filed May 15, 2025 20:20 UTC | Solventum Corp SOLV · Entity 1645 | Tax withholdingCommon Stock | 3,918 | $73.52 | $288,051.36 |
DisclosureSEC source: 0001628280-25-025944 · wk-form4_1747340424.xml · nonDerivative · entry 2 McMillan Wayde D. · CIK 0001768648 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,492 Read SEC document |
| May 13, 2025 Filed May 15, 2025 20:20 UTC | Solventum Corp SOLV · Entity 1645 | Exercise / conversionCommon Stock | 9,502 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-025944 · wk-form4_1747340424.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,410 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 07, 2025 Filed Apr 9, 2025 20:16 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 5,171 | $0.00 Strike: $61.27 | $0.00 |
DisclosureSEC source: 0001127602-25-011851 · form4.xml · derivative · entry 2 McMillan Wayde D. · CIK 0001768648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,171 Underlying: Common Stock · 5,171 shares Expires 2035-04-07 F3 · derivative.exercise_date: Options become exercisable on the date of the 2026 Annual Meeting of Stockholders. Read SEC document |
| April 07, 2025 Filed Apr 9, 2025 20:16 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 1,742 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-011851 · form4.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,742 F1 · shares: Represents restricted stock units which vest on the date of the 2026 Annual Meeting of Stockholders and are settled in shares of common stock. F2 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 20:43 UTC | Solventum Corp SOLV · Entity 1645 | GrantRestricted Stock Units · Derivative | 26,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-011727 · wk-form4_1741639386.xml · derivative · entry 1 McMillan Wayde D. · CIK 0001768648 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,407 Underlying: Common Stock · 26,407 shares Expires 2035-03-06 F1 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement. F2 · derivative.exercise_date: The RSUs shall fully vest in three tranches, with one-third vesting on each of the first, second and third anniversaries of the grant date, subject to continued service through the vesting date. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 22:39 UTC | Solventum Corp SOLV · Entity 1645 | Exercise / conversionRestricted Stock Units · Derivative | 28,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001964738-24-000063 · wk-form4_1733265565.xml · derivative · entry 3 McMillan Wayde D. · CIK 0001768648 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,010 Underlying: Common Stock · 28,010 shares Expires 2034-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement. F4 · derivative.exercise_date: The RSUs shall fully vest in two tranches, with one-half vesting on each of the first and second anniversaries of the grant date, subject to continued service through the vesting date. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 22:39 UTC | Solventum Corp SOLV · Entity 1645 | Tax withholdingCommon Stock | 11,112 | $71.51 | $794,619.12 |
DisclosureSEC source: 0001964738-24-000063 · wk-form4_1733265565.xml · nonDerivative · entry 2 McMillan Wayde D. · CIK 0001768648 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,903 Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 22:39 UTC | Solventum Corp SOLV · Entity 1645 | Exercise / conversionCommon Stock | 28,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001964738-24-000063 · wk-form4_1733265565.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects vesting of Solventum RSUs received upon conversion of previously granted 3M RSUs. Each 3M RSU converted into the number of Solventum RSUs equal to the number of 3M Shares subject to such 3M RSU Award immediately prior to the Effective Time of the separation, multiplied by the SpinCo Ratio as set forth in the Employee Matters Agreement entered into in connection with the separation. F2 · balance_after: Includes 5 shares held by the Reporting Person after conversion of 22 shares of 3M common stock he held prior to the spin-off from 3M that were converted to issuer's shares of stock at a ratio of one share of issuer's stock for every four shares of 3M stock, as described in the issuer's Information Statement filed with the SEC on February 20, 2024. Read SEC document |
| May 13, 2024 Filed May 15, 2024 20:56 UTC | Solventum Corp SOLV · Entity 1645 | GrantRestricted Stock Units · Derivative | 28,509 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015493 · form4.xml · derivative · entry 1 McMillan Wayde D. · CIK 0001768648 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,509 Underlying: Common Stock · 28,509 shares Expires 2034-05-13 F1 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement. F2 · derivative.exercise_date: The RSUs shall fully vest in three tranches, with one-third vesting on each of May 13, 2025; May 13, 2026; and May 13, 2027, subject to continued service through the vesting date. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 20:11 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 1,388 | $282.94 | $392,720.72 |
DisclosureSEC source: 0001127602-23-020391 · form4.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,477 F1 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $281.15 to $286.61. Specifically: 503 shares were sold in the range of $281.15 to $281.79, with a weighted average share price of $281.53; 210 shares were sold in the range of $282.37 to $283.37, with a weighted average share price of $283.01; F2 · price: Footnote continued: 588 shares were sold in the range of $283.44 to $284.39 with a weighted average share price of $283.81; 70 shares were sold at a price of $284.70; and 17 shares were sold at a price of $286.61. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 22:11 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 1,255 | $318.31 | $399,479.05 |
DisclosureSEC source: 0001127602-23-012414 · form4.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,865 F1 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $315.20 to $320.06. Specifically: 318 shares were sold in the range of $315.20 to $316.06, with a weighted average share price of $315.60; 84 shares were sold at a price of $316.68; 36 shares were sold at a price of $318.84; and 817 shares were sold in the range of $319.075 to $320.06, with a weighted average share price of $319.51. F2 · price: Footnote continued: The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 22:48 UTC | INSULET CORP PODD · Entity 3516 | GrantEmployee Stock Option (Right to Buy) · Derivative | 6,503 | $0.00 Strike: $276.36 | $0.00 |
DisclosureSEC source: 0001127602-23-007992 · form4.xml · derivative · entry 3 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,503 Underlying: Common Stock · 6,503 shares Expires 2033-02-28 F3 · derivative.exercise_date: Annual Non-Qualified Stock Option ("Option") Award. The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 22:48 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 2,713 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-007992 · form4.xml · nonDerivative · entry 2 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,120 F2 · shares: Annual Restricted Stock Unit ("RSU") award. RSUs vest in equal installments on each of the first, second and third anniversaries of the grant date and are settled in shares of common stock on a one-for-one basis. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 22:48 UTC | INSULET CORP PODD · Entity 3516 | Tax withholdingCommon Stock | 350 | $276.36 | $96,726.00 |
DisclosureSEC source: 0001127602-23-007992 · form4.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,407 F1 · shares: This transaction represents the withholding of shares upon the vesting of restricted stock units to cover the associated tax obligations. Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 21:19 UTC | INSULET CORP PODD · Entity 3516 | Tax withholdingCommon Stock | 1,092 | $296.00 | $323,232.00 |
DisclosureSEC source: 0001127602-23-006184 · form4.xml · nonDerivative · entry 3 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,757 F3 · shares: This transaction represents the withholding of shares upon the vesting of performance share units to cover the associated tax obligations. Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 21:19 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 3,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-006184 · form4.xml · nonDerivative · entry 2 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,849 F2 · shares: Represents shares issued upon the satisfaction of performance criteria related to Performance Share Units ("PSUs"). The PSUs were settled in shares of common stock on a one-for-one basis. Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 21:19 UTC | INSULET CORP PODD · Entity 3516 | Tax withholdingCommon Stock | 153 | $296.00 | $45,288.00 |
DisclosureSEC source: 0001127602-23-006184 · form4.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,637 F1 · shares: This transaction represents the withholding of shares upon the vesting of restricted stock units to cover the associated tax obligations. Read SEC document |
| February 10, 2023 Filed Feb 13, 2023 21:26 UTC | INSULET CORP PODD · Entity 3516 | Tax withholdingCommon Stock | 205 | $294.83 | $60,440.15 |
DisclosureSEC source: 0001127602-23-004863 · form4.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,790 F1 · shares: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 21:32 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 1,359 | $286.43 | $389,258.37 |
DisclosureSEC source: 0001127602-23-000512 · form4.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,995 F1 · shares: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. F2 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $283.33 to $300. Specifically: 140 shares were sold in the range of $283.33 to $284.29, with a weighted average share price of $283.81; 490 shares were sold in the range of $284.58 to $285.39, with a weighted average share price of $285.10; 211 shares were sold in the range of $285.85 to $286.55, with a weighted average share price of $286.27; 230 shares were sold in the range of $286.64 to $287.40, with a weighted average share price of $286.92; F3 · price: Footnote continued:140 shares were sold in the range of $288.01 to $288.52, with a weighted average share price of $288.27; 138 shares were sold in the range of $290.48 to $290.49, with a weighted average share price of $290.49; 5 shares were sold at a price of $298.12 and 5 shares were sold at a price of $300. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:15 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 1,455 | $275.60 | $400,998.00 |
DisclosureSEC source: 0001127602-22-011546 · form4.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,354 F1 · shares: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. F2 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $269.18 to $278.63. Specifically:108 shares were sold at $269.18 per share; 20 shares were sold at $273.24 per share; 361 shares were sold in the range of $274.05 to $274.98 per share, with a weighted average share price of $274.63; 351 shares were sold in the range of $275.16 to $276.01 per share, with a weighted average share price of $275.65; 395 shares were sold in the range of $276.48 to $277.38 per share, with a weighted average share price of $276.87; 192 shares were sold in the range of $277.48 to $278.45 per share, with a weighted average share price of $278.13; 28 shares were sold in the range of $278.48 to $278.63 per share, with a weighted average share price of $278.58. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:43 UTC | INSULET CORP PODD · Entity 3516 | Tax withholdingCommon Stock | 3,134 | $260.84 | $817,472.56 |
DisclosureSEC source: 0001127602-22-007729 · form4.xml · nonDerivative · entry 2 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,809 F2 · shares: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 21:43 UTC | INSULET CORP PODD · Entity 3516 | GrantEmployee Stock Option (Right to Buy) · Derivative | 6,500 | $0.00 Strike: $264.69 | $0.00 |
DisclosureSEC source: 0001127602-22-007729 · form4.xml · derivative · entry 3 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock · 6,500 shares Expires 2032-02-28 F3 · derivative.exercise_date: Annual Non-Qualified Stock Option ("Option") Award. The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 21:43 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 2,361 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-007729 · form4.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,943 F1 · shares: Annual Restricted Stock Unit ("RSU") award. RSUs vest in equal installments on each of the first, second and third anniversaries of the grant date and are settled in shares of common stock on a one-for-one basis. Read SEC document |
| February 26, 2022 Filed Feb 28, 2022 21:17 UTC | INSULET CORP PODD · Entity 3516 | Tax withholdingCommon Stock | 522 | $262.37 | $136,957.14 |
DisclosureSEC source: 0001127602-22-007009 · form4.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,582 F1 · shares: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations. Read SEC document |
| February 18, 2022 Filed Feb 22, 2022 21:32 UTC | INSULET CORP PODD · Entity 3516 | Tax withholdingCommon Stock | 2,673 | $234.18 | $625,963.14 |
DisclosureSEC source: 0001127602-22-006035 · form4.xml · nonDerivative · entry 2 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,104 F2 · shares: This transaction represents the withholding of shares upon the vesting of performance share units to cover the associated tax obligations. Read SEC document |
| February 18, 2022 Filed Feb 22, 2022 21:32 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 7,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006035 · form4.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,777 F1 · shares: Represents shares issued upon the satisfaction of performance criteria related to Performance Share Units ("PSUs"). The PSUs were settled in shares of common stock on a one-for-one basis. Read SEC document |
| February 17, 2022 Filed Feb 18, 2022 21:28 UTC | INSULET CORP PODD · Entity 3516 | Tax withholdingCommon Stock | 153 | $240.81 | $36,843.93 |
DisclosureSEC source: 0001127602-22-005765 · form4.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,720 Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:18 UTC | INSULET CORP PODD · Entity 3516 | Tax withholdingCommon Stock | 205 | $252.81 | $51,826.05 |
DisclosureSEC source: 0001127602-22-004559 · form4.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,873 Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 21:19 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 90 | $271.23 | $24,410.70 |
DisclosureSEC source: 0001127602-22-000457 · form4.xml · nonDerivative · entry 5 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,078 F1 · shares: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 21:19 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 672 | $270.19 | $181,567.68 |
DisclosureSEC source: 0001127602-22-000457 · form4.xml · nonDerivative · entry 4 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,168 F1 · shares: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. F5 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $269.86 to $270.55. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 21:19 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 500 | $268.88 | $134,440.00 |
DisclosureSEC source: 0001127602-22-000457 · form4.xml · nonDerivative · entry 3 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,840 F1 · shares: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. F4 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $268.47 to $269.36. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 21:19 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 400 | $267.82 | $107,128.00 |
DisclosureSEC source: 0001127602-22-000457 · form4.xml · nonDerivative · entry 2 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,340 F1 · shares: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. F3 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $267.45 to $268.11. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 21:19 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 193 | $266.37 | $51,409.41 |
DisclosureSEC source: 0001127602-22-000457 · form4.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,740 F1 · shares: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. F2 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $266.04 to $266.54. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:15 UTC | INSULET CORP PODD · Entity 3516 | Tax withholdingCommon Stock | 2,847 | $270.26 | $769,430.22 |
DisclosureSEC source: 0001127602-21-008705 · form4.xml · nonDerivative · entry 2 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,933 F1 · shares: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:15 UTC | INSULET CORP PODD · Entity 3516 | Tax withholdingCommon Stock | 346 | $259.10 | $89,648.60 |
DisclosureSEC source: 0001127602-21-008705 · form4.xml · nonDerivative · entry 1 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,780 F1 · shares: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 21:19 UTC | INSULET CORP PODD · Entity 3516 | GrantEmployee Stock Option (Right to Buy) · Derivative | 4,553 | $0.00 Strike: $279.69 | $0.00 |
DisclosureSEC source: 0001127602-21-006744 · form4.xml · derivative · entry 2 McMillan Wayde D. · CIK 0001768648 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,553 Underlying: Common Stock · 4,553 shares Expires 2031-02-17 F2 · derivative.exercise_date: Annual Non-Qualified Stock Option ("Option") Award. The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.